For example, galunisertib plays a crucial role in the treatment of malignant gliomas, including newly diagnosed and recurrent GBM, where TGF‐β promotes tumor cell survival, invasion, and immune evasion [258]. The gene discussed is TGFB1; the disease is glioblastoma.